SEC Form 4 · accession 0001651844-16-000016
NYMOX PHARMACEUTICAL CORP · NYMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James George Robinson
Director
Period of report
Apr 28, 2016
Accepted (ET)
Apr 29, 2016 · 5:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001018735
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 28, 2016 | P | 5,000 | $2.24 | A | 2,762,550 | D | |
| Common Stock | Apr 28, 2016 | P | 4,217 | $2.24 | A | 2,766,767 | D | |
| Common Stock | Apr 29, 2016 | P | 4,500 | $2.31 | A | 2,771,267 | D | |
| Common Stock | Apr 29, 2016 | P | 1,283 | $2.31 | A | 2,772,550 | D | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust |
Table II — derivative securities
No Table II lines on this filing.